Research Institute of Wildlife Ecology, Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Vet Anaesth Analg. 2020 Jul;47(4):518-527. doi: 10.1016/j.vaa.2019.10.011. Epub 2020 Mar 29.
To determine the effect of intravenous vatinoxan administration on bradycardia, hypertension and level of anaesthesia induced by medetomidine-tiletamine-zolazepam in red deer (Cervus elaphus).
A total of 10 healthy red deer were included in a randomised, controlled, experimental, crossover study.
Deer were administered a combination of 0.1 mg kg medetomidine hydrochloride and 2.5 mg kg tiletamine-zolazepam intramuscularly, followed by 0.1 mg kg vatinoxan hydrochloride or equivalent volume of saline intravenously (IV) 35 minutes after anaesthetic induction. Heart rate (HR), mean arterial blood pressure (MAP), respiration rate (f), end-tidal CO (Pe'CO), arterial oxygen saturation (SpO), rectal temperature (RT) and level of anaesthesia were assessed before saline/vatinoxan administration (baseline) and at intervals for 25 minutes thereafter. Differences within treatments (change from baseline) and between treatments were analysed with linear mixed effect models (p < 0.05).
Maximal (81 ± 10 beats minute) HR occurred 90 seconds after vatinoxan injection and remained significantly above baseline (42 ± 4 beats minute) for 15 minutes. MAP significantly decreased from baseline (122 ± 10 mmHg) to a minimum MAP of 83 ± 6 mmHg 60 seconds after vatinoxan and remained below baseline until end of anaesthesia. HR remained unchanged from baseline (43 ± 5 beats minute) with the saline treatment, whereas MAP decreased significantly (112 ± 16 mmHg) from baseline after 20 minutes. Pe'CO, f and SpO showed no significant differences between treatments, whereas RT decreased significantly 25 minutes after vatinoxan. Level of anaesthesia was not significantly influenced by vatinoxan.
Vatinoxan reversed hypertension and bradycardia induced by medetomidine without causing hypotension or affecting the level of anaesthesia in red deer. However, the effect on HR subsided 15 minutes after vatinoxan IV administration. Vatinoxan has the potential to reduce anaesthetic side effects in non-domestic ruminants immobilised with medetomidine-tiletamine-zolazepam.
确定静脉给予瓦替诺生对马兜铃酸-替马咪胺-唑拉西泮诱导的红鹿( Cervus elaphus )心动过缓、高血压和麻醉水平的影响。
共纳入 10 只健康红鹿进行随机、对照、实验、交叉研究。
鹿接受 0.1mg/kg盐酸右美托咪定和 2.5mg/kg替马咪胺-唑拉西泮肌肉注射,麻醉诱导后 35 分钟静脉内给予 0.1mg/kg盐酸瓦替诺生或等容量生理盐水。在给予生理盐水/瓦替诺生之前(基线)和之后 25 分钟的时间间隔内评估心率(HR)、平均动脉血压(MAP)、呼吸频率(f)、呼气末二氧化碳(Pe'CO)、动脉血氧饱和度(SpO)、直肠温度(RT)和麻醉水平。用线性混合效应模型分析治疗内(从基线变化)和治疗间的差异(p<0.05)。
瓦替诺生注射后 90 秒出现最大 HR(81±10 次/分钟),并持续 15 分钟显著高于基线(42±4 次/分钟)。MAP 从基线(122±10mmHg)显著下降至 60 秒时的最小 MAP83±6mmHg,并持续低于基线直至麻醉结束。生理盐水治疗 HR 从基线(43±5 次/分钟)保持不变,而 MAP 从 20 分钟后显著下降。治疗之间 Pe'CO、f 和 SpO 无显著差异,而瓦替诺生后 25 分钟 RT 显著下降。麻醉水平不受瓦替诺生影响。
瓦替诺生逆转了马兜铃酸-替马咪胺诱导的高血压和心动过缓,而不会引起低血压或影响红鹿的麻醉水平。然而,静脉给予瓦替诺生后 15 分钟,HR 作用消退。瓦替诺生有可能减少非 domestic ruminants 用马兜铃酸-替马咪胺-唑拉西泮固定时的麻醉副作用。